Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've noticed haemorrhoid symptoms since starting Mounjaro, or you're wondering whether tirzepatide and haemorrhoids are connected, the short answer is this: haemorrhoids are not listed as a known side effect of tirzepatide in the UK prescribing information, but the medicine's effect on bowel habits can create conditions where existing haemorrhoids flare or new ones develop. Mounjaro slows how quickly food moves through your digestive system, and the constipation that sometimes follows is one of the most common reasons haemorrhoid symptoms worsen during treatment. Understanding the link matters because the fix is usually straightforward — and because a prescriber needs to know what you're experiencing before you try to manage it yourself. Mounjaro is a prescription-only medicine; clinical oversight throughout treatment isn't optional box-ticking.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: a few weeks into Mounjaro, your appetite has dropped noticeably, you're eating less, and the nausea has started to settle. But somewhere along the way your bowel routine has shifted. You're going less often, and when you do, straining has become part of the process. If haemorrhoid symptoms have appeared around the same time, that sequence is almost certainly not a coincidence.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only medicine of its kind licensed in the UK for weight management. One of the ways it works is by slowing gastric emptying, which prolongs the feeling of fullness. That same mechanism affects transit time throughout the gut. When stool moves more slowly, water is absorbed for longer, leaving it drier and firmer by the time it reaches the rectum. The result is the kind of constipation that puts sustained downward pressure on the anal canal, exactly the mechanical environment in which haemorrhoids form or flare.
The NHS medicines page for tirzepatide lists constipation among the common side effects, alongside nausea, diarrhoea and indigestion. Haemorrhoids themselves do not appear in the list, which reflects the clinical trial data: the SURMOUNT programme recorded GI events, but haemorrhoids were not reported at a frequency that met the threshold for a named side effect. That said, absence from the side-effect list is not the same as impossible, constipation-driven haemorrhoid symptoms are a logical downstream consequence, and prescribers see it in practice.
On Mounjaro, most people eat considerably less. That's the point. But eating less can quietly pull fibre and fluid intake down at the same time, especially if the foods you can manage are plainer or lower in vegetables. Fibre bulks and softens stool; water keeps it moving. Lose both and the constipation risk compounds the effect tirzepatide is already having on gut transit.
Protein adequacy is a separate concern on GLP-1 treatment (muscle loss is a real risk when calories fall sharply) but from a bowel-health perspective, a treatment diet that skews heavily towards protein and away from vegetables and wholegrains can make haemorrhoid symptoms more likely. The practical adjustment isn't complicated: prioritise vegetables, pulses and oats where appetite allows, drink water consistently through the day (not just at meals), and keep moving. Walking stimulates bowel motility in a way that sitting still doesn't.
If you're thinking about the cost of managing treatment alongside everyday life, our Mounjaro pricing guide covers what a private prescription realistically involves.
One thing worth flagging: over-the-counter remedies for constipation or haemorrhoids (including laxatives and suppositories) can interact with how your gut responds to tirzepatide. Check with a pharmacist or prescriber before adding anything new to your routine. That conversation is easier when you have a prescriber who already knows your full picture, which is exactly what clinical oversight through a regulated service provides.
Most haemorrhoid flare-ups during Mounjaro treatment settle with the straightforward measures above. But some symptoms warrant prompt attention rather than watchful waiting.
Bright red rectal bleeding that is more than a small smear on the tissue, pain that is persistent and severe, or any symptom that doesn't improve within a week or two of dietary adjustment should be assessed by a GP. These can reflect haemorrhoids, but they can also reflect other conditions that require a different diagnosis altogether. A prescriber reviewing your Mounjaro treatment may adjust your dose, recommend a slower titration, or suggest a temporary pause while symptoms settle, none of which you can do safely without clinical input.
It's also worth knowing that tirzepatide causes diarrhoea in some people, especially in the early weeks of treatment or after a dose increase. Paradoxically, alternating between loose stools and constipation puts significant strain on haemorrhoidal tissue. If your bowel pattern is unpredictable rather than consistently constipated, that context matters when your prescriber is deciding what to recommend. You can read a broader overview of tirzepatide's mechanism and licensed use on our tirzepatide information page.
For anyone on Mounjaro who is also taking other medicines, including corticosteroids, the interaction picture can be more complex, our page on Mounjaro and steroids covers what's known there. And if you've come across questions about cognitive changes during treatment, Mounjaro and memory addresses those separately. If you have questions about gynaecological conditions and treatment, our page on Mounjaro and fibroids covers what the evidence currently shows.
The pen sits in the fridge door, you take it once a week, and for the most part the routine becomes invisible. What shouldn't become invisible is a symptom that's been quietly bothering you for several weeks. Haemorrhoids are common, often embarrassing to mention, and easy to manage when caught early, but they can become genuinely uncomfortable if ignored.
Here's a clear-headed summary of what helps most people:
Increase dietary fibre gradually (sudden large increases can worsen bloating on GLP-1 treatment). Drink consistently, aim for pale yellow urine as a rough guide rather than chasing a fixed litre target. Avoid prolonged sitting on the toilet. Use the toilet when the urge arises rather than deferring it. Topical treatments can ease discomfort but don't address the underlying constipation causing it.
If symptoms are new, worsening, or don't respond to those measures within ten to fourteen days, raise it with your prescriber. At nume, a real clinician reviews every patient's situation, you can find out more about the clinical team on our clinical oversight page. If you have questions about your treatment more broadly, our FAQs cover the questions that come up most often, and if you've seen Mounjaro discussed in online groups or messaging apps, our guide to Mounjaro on Telegram explains what to be cautious about when sourcing information that way.
Mounjaro is a prescription medicine assessed and managed individually. Symptoms that seem minor are still worth mentioning, they help your prescriber make better decisions about your treatment. If you'd like that clinical conversation, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.